Administration of Antenatal Corticosteroids: Optimal Timing.

Area of Science:

• Perinatology
• Neonatology
• Maternal-Fetal Medicine

Background:

• Antenatal corticosteroids (ACS) are vital for fetal lung maturation, reducing respiratory distress syndrome (RDS).
• The therapeutic window for ACS is critical; efficacy wanes, and risks increase beyond seven days post-administration.
• Adverse neurodevelopmental outcomes are noted in term infants exposed to ACS.

Purpose of the Study:

• To analyze the critical timing of antenatal corticosteroid (ACS) administration for optimal outcomes.
• To review indications for ACS in various high-risk pregnancies.
• To highlight the need for improved prediction of preterm birth for precise ACS timing.

Main Methods:

• Review of existing literature on antenatal corticosteroid (ACS) efficacy and timing.
• Analysis of specific obstetric indications for ACS administration.
• Discussion of diagnostic challenges in predicting preterm birth and intra-amniotic infection.

Main Results:

• Optimal ACS benefit is achieved when delivery occurs 24 hours to 7 days post-administration.
• Current optimal timing is achieved in only 25-40% of indicated cases.
• Specific conditions like PPROM, severe pre-eclampsia, IUGR, and preterm labor <15mm cervical length warrant ACS.

Conclusions:

• Precise timing of antenatal corticosteroids (ACS) is paramount for efficacy and safety.
• Improved predictive diagnostics for preterm birth are essential for optimizing ACS use.
• Clinical expertise is crucial for determining ACS indications, especially in complex cases.